Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)

ClinicalTrials.gov ID: NCT05507450

Public ClinicalTrials.gov record NCT05507450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Three Different Potency Levels of V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) in Healthy Adults

Study identification

NCT ID
NCT05507450
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,271 participants

Conditions and interventions

Interventions

  • V181 High-Potency Level Biological
  • V181 Mid-Potency Level Biological
  • V181 Low-Potency Level Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 6, 2022
Primary completion
Jun 4, 2023
Completion
May 6, 2024
Last update posted
May 8, 2025

2022 – 2024

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
California Research Foundation ( Site 0114) San Diego California 92123
Advanced Medical Research Institute ( Site 0115) Miami Florida 33174
Rochester Clinical Research, Inc. ( Site 0122) Rochester New York 14609
University of Texas Medical Branch ( Site 0113) Galveston Texas 77555
IMA Clinical Research San Antonio ( Site 0111) San Antonio Texas 78229
Alliance for Multispecialty Research LLC (AMR - Norfolk) ( Site 0123) Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05507450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05507450 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →